Sinequan 150mg Caps

Manufacturer PFIZER U.S. Active Ingredient Doxepin Capsules(DOKS e pin) Pronunciation DOKS e pin
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant, Anxiolytic, Hypnotic, Antipruritic
đŸ§Ŧ
Pharmacologic Class
Tricyclic Antidepressant (TCA), Histamine H1 Receptor Antagonist
🤰
Pregnancy Category
C
✅
FDA Approved
Mar 1969
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Doxepin is a medication that can help improve mood, reduce anxiety, help with sleep, or relieve itching. It works by affecting certain natural chemicals in the brain. It's important to take it exactly as prescribed, as doses vary greatly depending on what it's being used for.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. If you are taking this medication once a day, take it at bedtime. Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel well.

Storing and Disposing of Your Medication

To maintain the effectiveness and safety of your medication, store it at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a secure location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so. Instead, check with your pharmacist for guidance on the best disposal method. You may also want to inquire about drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Avoid alcohol and other sedating medications, as doxepin can increase drowsiness.
  • Be cautious when driving or operating machinery until you know how this medication affects you.
  • To minimize dizziness or lightheadedness, especially when starting or increasing dose, get up slowly from a sitting or lying position.
  • Manage dry mouth with sugar-free candy, gum, or artificial saliva.
  • Increase fiber and fluid intake to help with constipation.
  • Report any new or worsening mood changes, thoughts of self-harm, or unusual behaviors to your doctor immediately.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For depression/anxiety: 75 mg/day orally in a single dose or divided doses. For insomnia: 3-6 mg orally once daily, 30 minutes before bedtime. For pruritus: 10-30 mg orally once daily.
Dose Range: 10 - 300 mg

Condition-Specific Dosing:

Depression/Anxiety (moderate to severe): Initial: 25-50 mg/day, gradually increased to 75-150 mg/day. Max: 300 mg/day.
Insomnia (Silenor formulation): 3 mg or 6 mg orally once daily, 30 minutes before bedtime.
Pruritus (urticaria/eczema): 10-30 mg orally once daily, usually at bedtime.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for depression/anxiety. Use for pruritus (topical) or severe insomnia (oral, off-label, with caution).
Adolescent: Not established for depression/anxiety. Use with extreme caution due to Black Box Warning for suicidality. Initial 25-50 mg/day, max 150 mg/day.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, monitor for adverse effects.
Moderate: No specific dose adjustment recommended, monitor for adverse effects.
Severe: Use with caution, consider lower doses and monitor for adverse effects due to potential accumulation of parent drug and active metabolite.
Dialysis: Not well studied. Doxepin is highly protein bound, so unlikely to be significantly removed by dialysis. Use with caution, consider lower doses.

Hepatic Impairment:

Mild: Use with caution, consider lower doses.
Moderate: Significant dose reduction may be necessary (e.g., 50% or more). Monitor plasma levels if available.
Severe: Contraindicated or not recommended due to extensive hepatic metabolism and risk of accumulation and toxicity.
Confidence: Medium

Pharmacology

đŸ”Ŧ

Mechanism of Action

Doxepin is a tricyclic antidepressant (TCA) that primarily inhibits the reuptake of norepinephrine and serotonin at presynaptic neuronal membranes, thereby increasing the concentration of these neurotransmitters in the synaptic cleft. It also possesses potent antihistaminic (H1 and H2), anticholinergic, and alpha-1 adrenergic blocking properties, which contribute to its sedative, anxiolytic, and adverse effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable, approximately 20-45% due to significant first-pass metabolism.
Tmax: 2-4 hours (parent drug), 4-8 hours (active metabolite, nordoxepin).
FoodEffect: Food may delay absorption but does not significantly affect the extent of absorption.

Distribution:

Vd: 9-33 L/kg (extensive tissue distribution).
ProteinBinding: Approximately 80-85% (doxepin) and 76% (nordoxepin) to plasma proteins.
CnssPenetration: Yes, readily crosses the blood-brain barrier.

Elimination:

HalfLife: Doxepin: 10-25 hours; Nordoxepin: 28-80 hours.
Clearance: Not precisely quantified, but extensive hepatic metabolism.
ExcretionRoute: Primarily renal (as metabolites).
Unchanged: <3% (parent drug) in urine.
âąī¸

Pharmacodynamics

OnsetOfAction: Sedation/hypnotic effects: within 30-60 minutes. Antidepressant effects: 2-4 weeks.
PeakEffect: Sedation/hypnotic effects: 1-3 hours. Antidepressant effects: 4-6 weeks.
DurationOfAction: Sedation/hypnotic effects: 7-8 hours (low dose). Antidepressant effects: sustained with chronic dosing due to long half-life of parent drug and active metabolite.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of doxepin or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Fast heartbeat
Difficulty urinating
Feeling extremely nervous or excitable
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Yellowing of the skin or eyes (jaundice)
Ringing in the ears (tinnitus)
Changes in sex interest
Enlarged breasts or nipple discharge
Swelling of the testicles

Important Warning for Asthma Patients

If you have asthma, use this medication with caution. Worsening of asthma has been reported in people taking this medication. If your asthma symptoms worsen while taking this medication, contact your doctor right away.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. However, if you notice any of the following side effects or if they bother you or do not go away, contact your doctor or seek medical help:

Feeling dizzy, sleepy, tired, or weak
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Dry mouth
Changes in taste
Mouth irritation or mouth sores
Weight gain
Excessive sweating
Flushing
Hair loss
* Headache

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or anxiety
  • Thoughts of harming yourself
  • Feeling agitated, restless, or irritable
  • Panic attacks
  • Difficulty sleeping (insomnia)
  • Acting on dangerous impulses
  • Extreme increase in activity and talking (mania)
  • Severe dizziness or fainting
  • Fast or irregular heartbeat
  • Difficulty urinating
  • Severe constipation or abdominal pain
  • Blurred vision or eye pain
  • Unexplained fever, sore throat, or unusual bleeding/bruising
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
Certain health conditions, including:
+ Urinary retention or glaucoma
Current or recent use of specific medications, including:
+ Linezolid or methylene blue
+ Monoamine oxidase inhibitors (MAOIs) for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days, as this may lead to severely high blood pressure
Use of other medications that can cause drowsiness, as there are many drugs with this potential effect. If you are unsure, consult your doctor or pharmacist.
* If you are breastfeeding, as you should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other drugs and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Before engaging in activities that require alertness, such as driving, wait until you understand how this drug affects you.

Please note that it may take several weeks to experience the full effects of this medication. Do not abruptly stop taking this drug without consulting your doctor, as this may increase your risk of side effects. If you need to discontinue this medication, your doctor will provide guidance on how to gradually stop taking it.

While taking this medication, avoid consuming alcohol. Additionally, consult your doctor before using marijuana, cannabis, or prescription or over-the-counter (OTC) drugs that may cause drowsiness or slow your reactions.

Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor immediately.

This medication may increase your sensitivity to the sun, making you more prone to sunburn. Take necessary precautions when spending time outdoors, and inform your doctor if you experience frequent sunburns while taking this medication.

If you have diabetes (high blood sugar), closely monitor your blood sugar levels. Be aware of signs of high or low blood sugar, such as fruity breath odor, dizziness, rapid breathing, rapid heartbeat, confusion, drowsiness, weakness, flushing, headache, unusual thirst or hunger, frequent urination, shaking, or sweating. Report any of these symptoms to your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

Some medications, including this one, may affect fertility and the ability to conceive. If you have concerns, discuss them with your doctor.

If you are pregnant or plan to become pregnant, consult your doctor to weigh the benefits and risks of taking this medication during pregnancy. Taking this drug in the third trimester may lead to health problems in the newborn, so it is crucial to discuss this with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Confusion or disorientation
  • Severe dry mouth
  • Blurred vision
  • Dilated pupils
  • Fast or irregular heartbeat (tachycardia, arrhythmias)
  • Low blood pressure (hypotension)
  • Urinary retention
  • Seizures
  • Respiratory depression
  • Hypothermia
  • Agitation or delirium (especially in early stages)

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic, including gastric lavage, activated charcoal, maintaining airway, monitoring cardiac function (ECG), and managing seizures or arrhythmias.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - risk of serotonin syndrome, hyperpyretic crises, convulsions, and death.
  • Cisapride - risk of QT prolongation and arrhythmias.
  • Patients with glaucoma or urinary retention (due to anticholinergic effects).
🔴

Major Interactions

  • CNS Depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics) - additive CNS depression.
  • Anticholinergic agents (e.g., atropine, benztropine, diphenhydramine) - additive anticholinergic effects (severe constipation, urinary retention, paralytic ileus, delirium).
  • Adrenergic neuron blocking agents (e.g., guanethidine, clonidine) - may block antihypertensive effects.
  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine) - increased doxepin levels and toxicity.
  • Thyroid hormones - increased risk of cardiac arrhythmias.
  • QT-prolonging drugs (e.g., antiarrhythmics, antipsychotics, macrolides, fluoroquinolones) - increased risk of QT prolongation and Torsades de Pointes.
🟡

Moderate Interactions

  • Cimetidine - increased doxepin levels.
  • Oral anticoagulants (e.g., warfarin) - potential for increased anticoagulant effect.
  • Sympathomimetics (e.g., epinephrine, norepinephrine) - enhanced pressor response.
  • Antihypertensives - additive hypotensive effects.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

ECG (Electrocardiogram)

Rationale: To assess for pre-existing cardiac conduction abnormalities or QT prolongation, especially in patients with cardiac disease or risk factors.

Timing: Prior to initiation, especially in elderly or those with cardiac risk factors.

Complete Blood Count (CBC) with differential

Rationale: To establish baseline and monitor for rare but serious hematologic abnormalities (e.g., agranulocytosis, thrombocytopenia).

Timing: Prior to initiation.

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function, as doxepin is extensively metabolized by the liver.

Timing: Prior to initiation.

Renal Function Tests (BUN, Creatinine)

Rationale: To assess baseline renal function, especially in elderly or those with known renal impairment.

Timing: Prior to initiation.

Intraocular Pressure (IOP)

Rationale: To assess for glaucoma, as doxepin has anticholinergic effects that can exacerbate narrow-angle glaucoma.

Timing: Prior to initiation in patients at risk or with history of glaucoma.

📊

Routine Monitoring

Mental Status and Suicidality

Frequency: Weekly during initial therapy (first 4-6 weeks), then monthly for first few months, then periodically.

Target: Improvement in mood/anxiety symptoms, absence of suicidal ideation/behavior.

Action Threshold: Worsening depression, emergence of suicidal thoughts/behavior, unusual changes in behavior (agitation, irritability, panic attacks, insomnia, impulsivity, akathisia, hypomania, mania) require immediate re-evaluation and potential dose adjustment or discontinuation.

Blood Pressure (BP) and Heart Rate (HR)

Frequency: Periodically, especially during dose titration and in elderly or those with cardiovascular disease.

Target: Within normal limits, absence of orthostatic hypotension.

Action Threshold: Significant orthostatic hypotension (drop >20 mmHg systolic or >10 mmHg diastolic), persistent tachycardia, or arrhythmias.

Anticholinergic Side Effects (e.g., dry mouth, constipation, blurred vision, urinary retention)

Frequency: Regularly, especially during initial therapy and dose increases.

Target: Minimal or manageable side effects.

Action Threshold: Severe or intolerable anticholinergic effects, especially urinary retention or paralytic ileus, require dose reduction or discontinuation.

Weight

Frequency: Periodically.

Target: Stable weight or within healthy range.

Action Threshold: Significant or undesirable weight gain.

Therapeutic Drug Monitoring (TDM) - Doxepin and Nordoxepin levels

Frequency: Not routinely recommended, but may be useful in cases of suspected non-adherence, poor response, or toxicity.

Target: Combined plasma levels of doxepin and nordoxepin for depression: 100-250 ng/mL (therapeutic range is debated and varies by lab).

Action Threshold: Levels outside therapeutic range, or in presence of toxicity/lack of efficacy.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Suicidal thoughts or behavior
  • Unusual changes in behavior (agitation, irritability, panic attacks, insomnia, impulsivity, akathisia, hypomania, mania)
  • Dry mouth
  • Constipation
  • Blurred vision
  • Urinary retention
  • Dizziness or lightheadedness (especially upon standing)
  • Sedation or drowsiness
  • Nausea
  • Headache
  • Tremor
  • Palpitations or irregular heartbeat
  • Confusion or disorientation (especially in elderly)

Special Patient Groups

🤰

Pregnancy

Doxepin is Pregnancy Category C. Studies in animals have shown adverse effects on the fetus, but there are no adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to TCAs in the third trimester may experience withdrawal symptoms (e.g., respiratory distress, feeding difficulties, irritability, tremors).

Trimester-Specific Risks:

First Trimester: Potential for increased risk of congenital malformations, though data are conflicting and not conclusive for TCAs as a class.
Second Trimester: Less data available, but generally considered lower risk for major malformations compared to first trimester.
Third Trimester: Risk of neonatal withdrawal symptoms (e.g., respiratory distress, cyanosis, apnea, seizures, feeding difficulties, hypotonia, hypertonia, tremor, irritability, persistent crying) if exposed close to delivery.
🤱

Lactation

Doxepin and its active metabolite nordoxepin are excreted into breast milk. The American Academy of Pediatrics considers doxepin to be a drug for which the effect on the nursing infant is unknown but may be of concern. Monitor infants for sedation, poor feeding, and weight gain. L3 (Moderately Safe) or L4 (Possibly Hazardous) depending on source and dose. Low doses (e.g., for insomnia) may pose less risk.

Infant Risk: Sedation, poor feeding, irritability, weight loss. Risk is generally considered low, but caution is advised, especially with higher doses or in preterm/neonatal infants.
đŸ‘ļ

Pediatric Use

Not approved for depression or anxiety in pediatric patients. Black Box Warning regarding increased risk of suicidality in children, adolescents, and young adults. Use for insomnia (Silenor) is not approved for pediatric patients. Topical doxepin cream is approved for pruritus in children â‰Ĩ12 years. Oral use in children for other indications is off-label and requires careful consideration of risks vs. benefits.

👴

Geriatric Use

Elderly patients are more sensitive to the anticholinergic, sedative, and hypotensive effects of doxepin. Start with lower doses (e.g., 10-25 mg/day for depression/anxiety, 3 mg for insomnia) and titrate slowly. Increased risk of falls, cognitive impairment, and cardiac adverse events (e.g., orthostatic hypotension, arrhythmias). Monitor closely for adverse effects.

Clinical Information

💎

Clinical Pearls

  • Doxepin's strong antihistaminic properties make it highly sedating, which is leveraged for its use in insomnia (Silenor, low dose) and pruritus.
  • The 150mg capsule is a high dose, typically reserved for severe depression or anxiety, and should be initiated with careful titration from lower doses.
  • Due to its long half-life, once-daily dosing (especially at bedtime) is often preferred for depression/anxiety to minimize daytime sedation.
  • Be aware of the significant anticholinergic side effects (dry mouth, constipation, urinary retention, blurred vision) and counsel patients on management strategies.
  • Orthostatic hypotension is a common and potentially serious side effect, especially in the elderly; advise patients to rise slowly.
  • Cardiac monitoring (ECG) is important, especially in patients with pre-existing cardiac disease or those receiving high doses, due to potential for QT prolongation and conduction abnormalities.
  • Avoid abrupt discontinuation, especially after prolonged use, to prevent withdrawal symptoms (e.g., nausea, headache, malaise, sleep disturbance, irritability).
🔄

Alternative Therapies

  • For Depression: SSRIs (e.g., fluoxetine, sertraline), SNRIs (e.g., venlafaxine, duloxetine), Atypical Antidepressants (e.g., bupropion, mirtazapine), other TCAs (e.g., amitriptyline, imipramine, nortriptyline).
  • For Anxiety: SSRIs, SNRIs, benzodiazepines (short-term), buspirone.
  • For Insomnia: Z-drugs (e.g., zolpidem, eszopiclone), ramelteon, suvorexant, other sedating antidepressants (e.g., mirtazapine, trazodone), antihistamines (e.g., diphenhydramine).
  • For Pruritus: Antihistamines (e.g., hydroxyzine, cetirizine), topical corticosteroids, other topical antipruritics.
💰

Cost & Coverage

Average Cost: Varies widely by dosage and quantity (e.g., $30-$200+) per 30 capsules
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic), Tier 3 or Non-Formulary (brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. It is vital to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the name of the medication, the amount taken, and the time it was taken.